Evidence map›Paper›PMID 36572860›Full record

ArticleBMC primary care2022

Dry needling for the treatment of acute myofascial pain syndrome in general practitioners' clinics: a cohort study.

Ilan Yehoshua, Oded Rimon, Miri Mizrahi Reuveni, Roni Peleg, Limor Adler

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06689371 (Dry Needling Versus Dry Cupping on Pain and Disability in Cervicogenic Headache Patients), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06689371 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

Dry Needling Versus Dry Cupping on Pain and Disability in Cervicogenic Headache Patients

TypeinterventionalSponsorCairo UniversityRan2024 to 2025Enrolled45ConditionsDry Needling, Dry Cupping, Cervicogenic HeadacheArmsGroup A (Dry Needling), Group B (Dry cupping), Group C (control)
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Observational
  4. Myofascial pain syndrome in the oncologic patient: general considerations.Medical oncology (Northwood, London, England) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ilan YehoshuaDepartment of Family Medicine, Maccabi Healthcare Service, 27 Hamered Street, Tel Aviv, Israel.
Oded RimonBen Gurion University, Beer Sheva, Israel.
Miri Mizrahi ReuveniDepartment of Family Medicine, Maccabi Healthcare Service, 27 Hamered Street, Tel Aviv, Israel.
Roni PelegBen Gurion University, Beer Sheva, Israel.
Limor AdlerDepartment of Family Medicine, Maccabi Healthcare Service, 27 Hamered Street, Tel Aviv, Israel. adler_l@mac.org.il.
Maccabi Health Care Services · ILBen-Gurion University of the Negev · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMusculoskeletal pain is one of the leading complaints in the ambulatory setting. There are many ways to treat it, including pharmacologic and non-pharmacologic approaches. Dry needling (DN) is an option that is easy to learn, cheap and has a good safety profile. The aim of this study was to assess the association between DN performed by GPs for acute myofascial pain syndrome (MPS) and pain relief and to evaluate factors associated with treatment success.

methodsIn this prospective cohort study, two GPs performed DN in their clinics. Patients were asked to rank their pain using the Short-Form McGill Pain Questionnaire (SF-MPQ) before, 10-min and 1-week after the procedure. The SF-MPQ index consists of 3 parts; visual analog scale (VAS), pain rating index (PRI) and present pain intensity (PPI). Logistic regressions were performed to assess the variables associated with short- and medium- term success.

resultsFifty two patients were recruited from September 2019 until August 2020. VAS was 6.0 ± 2.3 (before), 4.1 ± 2.5 (10-min after) and 2.6 ± 2.71 (1-week after), P < 0.05. PRI was 17 ± 9.1 (before), 10.8 ± 8.5 (10-min after) and 5.1 ± 6.5 (1-week after), P < 0.05. PPI was 2.6 ± 1.0 (before), 1.7 ± 1.0 (10-min after) and 1.1 ± 1.2 (1-week after), P < 0.05. Short-term success was associated with the physician who performed the procedure (OR 10.08, 95% CI 1.15,88.4) and with the use of a single needle (vs. multiple needles inserted) (OR 4.55, 95% CI 1.03,20.11). Medium-term success was associated with being a native born (non-immigrant), OR 8.59, 95% CI 1.11,66.28 and with high level of initial pain, OR 11.22, 95% CI 1.82,69.27.

conclusionOur study demonstrated improvement in acute pain 10-min and 1-week after DN performed by a GP, in all parts of the SF-MPQ. Therefore, we believe DN is a good therapeutic option for GPs to aid patients suffering from MPS.

Indexed as

Dry NeedlingFibromyalgiaGeneral PractitionersMyofascial Pain SyndromesCohort StudiesHumansPainProspective StudiesDry needlingGeneral practiceMyofascial pain syndromePrimary health care

Identifiers

PMID36572860
PMCPMC9792314
OpenAlexW4313250742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.